Communications & New Media Nov 2015 Vol 29 No 11
odwyers-magazine-november-2015
odwyers-magazine-november-2015
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Focusing on people-centric social media<br />
Patients are at the forefront of everything we do in the healthcare industry , making the notion of<br />
patient-centricity a worthwhile and noble concept. When it comes to social media, however, pharma<br />
needs to learn how to put the person before the patient.<br />
By Chris Iafolla<br />
Five years ago, the tendency for healthcare<br />
companies was to take a “hey,<br />
look at me — I’m on social media” approach.<br />
This is no longer sufficient.<br />
As healthcare marketers, we understand<br />
the distinct differences between our industry<br />
and less-regulated industries like<br />
consumer packaged goods, but consumers<br />
don’t make the delineation. They expect<br />
the same level of service, response and<br />
engagement out of pharmaceutical companies<br />
that they do out of their favorite<br />
beauty brand.<br />
The expectation is that pharmaceutical<br />
companies act like customer service organizations,<br />
disease education experts,<br />
science companies and patient-support<br />
groups all at once. This is becoming increasingly<br />
more important as election season<br />
kicks up and the cost of prescription<br />
medicine takes center stage and consumers<br />
begin examining these companies closer.<br />
When all of this converges, the drive to<br />
be patient-centric has accelerated and the<br />
focus on engagement through social media<br />
has intensified, but the question is: how do<br />
companies evolve their current approach<br />
to better fit this move to more patient-centric<br />
engagement?<br />
It’s the person, not the patient<br />
One key component to changing the<br />
way healthcare companies engage is to not<br />
think about the patient, and instead, think<br />
about the person. It’s a subtle difference<br />
that has major implications on how we<br />
produce content and engage with people<br />
across social media channels.<br />
Pharmaceutical companies tend to spend<br />
disproportionate amounts of budget on<br />
motivating people to seek a prescription. It<br />
makes sense. Without patients on therapy,<br />
pharmaceutical companies would cease to<br />
exist. However, when this thought process<br />
is pulled through to social media engagement,<br />
it begins to cause problems. A patient<br />
is a person first.<br />
A drive to patient-centricity should acknowledge<br />
this fact and be open to engaging<br />
with people outside of simply what<br />
defines a patient. This type of approach<br />
would inform content creation efforts that<br />
stretch outside of simple disease awareness<br />
activities and would include more material<br />
that fits into the daily life of the person. To<br />
truly engage with people on their level, we<br />
have to first understand that their lives exist<br />
outside of their condition.<br />
Human behavior is shaped by core values,<br />
emotional stimuli, aesthetic responses<br />
and other inputs, which are dynamic and<br />
volatile. That means even in a changing<br />
digital and social landscape, consumers<br />
will respond to well-crafted messages,<br />
trustworthy information and relationships<br />
that are cultivated to yield mutual benefits.<br />
The content premium<br />
For years, the words paid, earned, social<br />
and owned have been useful differentiators<br />
— and they still are. But in the healthcare<br />
setting, PESO feels like a blunt instrument.<br />
When the conversation is about illness or<br />
mortality, the biggest mistake is to treat social<br />
media as a push channel.<br />
Social media is undoubtedly an instrument<br />
that can deliver heightened engagement,<br />
but in healthcare, it is also a world<br />
inhabited by people with urgent and sensitive<br />
connections to the products companies<br />
provide. Often, as in other industries,<br />
an aspect of paid promotion will be<br />
required to elevate the story. But “paid” is<br />
wasted in this drive to put the patient at the<br />
center if the content isn’t valuable, the message<br />
isn’t unique and the human element<br />
isn’t immediately clear.<br />
Don’t avoid the important issues<br />
Because consumers now have an understanding<br />
that healthcare companies will<br />
engage with them, their level of expectation<br />
has increased. These people are accustomed<br />
to getting their questions answered<br />
by airlines, their appointment requests responded<br />
to by cable companies and their<br />
product complaints addressed directly by<br />
the manufacturer. The result is that people<br />
expect to be engaged on their terms,<br />
not those of the company. This is a tough<br />
one for healthcare companies operating in<br />
a highly-regulated environment where engagement<br />
on real issues is difficult.<br />
This means finding a way to communicate<br />
on pricing concerns, addressing patient<br />
questions regarding treatment and<br />
providing broad support to those living<br />
with certain conditions. It’s not an easy<br />
challenge to solve for a pharmaceutical<br />
company, and there are certain issues that<br />
lend themselves to other forms of communication,<br />
but a willingness to at least consider<br />
these topics is important.<br />
Healthcare companies operate in an environment<br />
where every communication<br />
carries weight — where people’s health is<br />
the primary topic. Because of this, social<br />
media is a unique tool to change the way<br />
we engage with our audience, but it requires<br />
a renewed focus<br />
on putting the person<br />
first.<br />
The companies that<br />
can find that balance<br />
of empathy, responsiveness<br />
and credibility<br />
will find the most longterm<br />
value on social<br />
media.<br />
Chris Iafolla is Head<br />
Chris Iafolla<br />
of Digital and Social Strategy at inVentiv<br />
Health Public Relations Group, which<br />
consists of Allidura Consumer, Biosector 2,<br />
Chamberlain Healthcare PR and Chandler<br />
Chicco Agency. <br />
PR news brief<br />
Cision debuts PR platform upgrade<br />
Cision on October 26 rolled out an upgrade to its<br />
PR platform encompassing the software company’s<br />
influencer marketing, media insights and mobile marketing<br />
tools.<br />
The upgrade is designed to improve the ability<br />
among PR professionals to find both media reps and<br />
influencers who are most likely interested in their story<br />
pitches.<br />
“what we’re trying to do with [the upgrade] is to<br />
build the right experience for PR and communications<br />
pros,” said Natalia Dykyj, VP of product management<br />
at Cision. “The upgrade is all about how do we expand<br />
our core capabilities and start to offer best of<br />
breed products.”<br />
Major upgrades to Cision’s PR platform include<br />
adding premium profiles from Gorkana, the media database<br />
company that Cision acquired last year for an<br />
undisclosed sum; enhanced influencer profile pages;<br />
influencer “streams” and influencer search.<br />
The upgrade also includes new social performance<br />
dashboards, email distribution improvements and<br />
Google Analytics integration.<br />
On the mobile front, as part of the upgrade Cision<br />
will now offer a new iOS mobile and curation.<br />
Users will be able to download the app to access<br />
a stream of their brand’s (or client’s) most important<br />
news coverage, with tools to curate and share news<br />
with internal stakeholders as well as social media<br />
followers.<br />
The product is available to Cision’s new and existing<br />
customers in the U.S., Canada, France and the<br />
United Kingdom.<br />
www.ODwyERPR.COM | NOVEMBER <strong>2015</strong> 35